BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23723416)

  • 1. Tissue-specific splicing of a ubiquitously expressed transcription factor is essential for muscle differentiation.
    Sebastian S; Faralli H; Yao Z; Rakopoulos P; Palii C; Cao Y; Singh K; Liu QC; Chu A; Aziz A; Brand M; Tapscott SJ; Dilworth FJ
    Genes Dev; 2013 Jun; 27(11):1247-59. PubMed ID: 23723416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rbfox proteins regulate tissue-specific alternative splicing of Mef2D required for muscle differentiation.
    Runfola V; Sebastian S; Dilworth FJ; Gabellini D
    J Cell Sci; 2015 Feb; 128(4):631-7. PubMed ID: 25609712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing.
    Martin JF; Miano JM; Hustad CM; Copeland NG; Jenkins NA; Olson EN
    Mol Cell Biol; 1994 Mar; 14(3):1647-56. PubMed ID: 8114702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
    Zhu B; Gulick T
    Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage.
    Breitbart RE; Liang CS; Smoot LB; Laheru DA; Mahdavi V; Nadal-Ginard B
    Development; 1993 Aug; 118(4):1095-106. PubMed ID: 8269842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEF2 proteins, including MEF2A, are expressed in both muscle and non-muscle cells.
    Dodou E; Sparrow DB; Mohun T; Treisman R
    Nucleic Acids Res; 1995 Nov; 23(21):4267-74. PubMed ID: 7501445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons.
    Salma J; McDermott JC
    J Neurosci; 2012 Feb; 32(8):2790-803. PubMed ID: 22357862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
    Zhang M; Zhu B; Davie J
    J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation.
    Choi SJ; Park SY; Han TH
    Nucleic Acids Res; 2001 Jul; 29(13):2836-42. PubMed ID: 11433030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-binding protein Muscleblind-like 3 (MBNL3) disrupts myocyte enhancer factor 2 (Mef2) {beta}-exon splicing.
    Lee KS; Cao Y; Witwicka HE; Tom S; Tapscott SJ; Wang EH
    J Biol Chem; 2010 Oct; 285(44):33779-87. PubMed ID: 20709755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons.
    Li M; Linseman DA; Allen MP; Meintzer MK; Wang X; Laessig T; Wierman ME; Heidenreich KA
    J Neurosci; 2001 Sep; 21(17):6544-52. PubMed ID: 11517243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional gene expression analysis of tissue-specific isoforms of Mef2c.
    Sekiyama Y; Suzuki H; Tsukahara T
    Cell Mol Neurobiol; 2012 Jan; 32(1):129-39. PubMed ID: 21842419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D.
    Du M; Perry RL; Nowacki NB; Gordon JW; Salma J; Zhao J; Aziz A; Chan J; Siu KW; McDermott JC
    Mol Cell Biol; 2008 May; 28(9):2952-70. PubMed ID: 18299387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells.
    Ornatsky OI; McDermott JC
    J Biol Chem; 1996 Oct; 271(40):24927-33. PubMed ID: 8798771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early expression of the different isoforms of the myocyte enhancer factor-2 (MEF2) protein in myogenic as well as non-myogenic cell lineages during mouse embryogenesis.
    Subramanian SV; Nadal-Ginard B
    Mech Dev; 1996 Jun; 57(1):103-12. PubMed ID: 8817457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating a master regulator: establishing tissue-specific gene expression in skeletal muscle.
    Aziz A; Liu QC; Dilworth FJ
    Epigenetics; 2010; 5(8):691-5. PubMed ID: 20716948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter.
    Mora S; Pessin JE
    J Biol Chem; 2000 May; 275(21):16323-8. PubMed ID: 10748204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
    Grégoire S; Yang XJ
    Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis.
    Singh RK; Xia Z; Bland CS; Kalsotra A; Scavuzzo MA; Curk T; Ule J; Li W; Cooper TA
    Mol Cell; 2014 Aug; 55(4):592-603. PubMed ID: 25087874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement of decreased O-GlcNAc glycosylation of Mef2D for its recruitment to the myogenin promoter.
    Ogawa M; Sakakibara Y; Kamemura K
    Biochem Biophys Res Commun; 2013 Apr; 433(4):558-62. PubMed ID: 23523791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.